This two-day course covers various issues and challenges in regulatory science for gene and cell-therapy medicinal products.
CPD approval by the Royal College of Pathologists.
Aimed at learners in a wide range of roles that regularly face challenges in production, testing and registration of advanced medicinal products (ATMPs), our course will:
As a wide range of novel gene and/or cell therapies are developed in clinical and preclinical studies, the important question of how to deliver potentially beneficial therapies to patients is often neglected.
In this course we'll discuss the regulations required to help make future medicinal products safe and effective, which evolve alongside advances in science and technology.
Learners will be taught by experts at UCL, the Medicines and Healthcare products Regulatory Agency, including specialists who work to develop and deliver NIBSC standards, and the Cell and Gene Therapy Catapult.
Course structure and teaching
The course will be taught on Monday 7th and Tuesday 8th November 2022.
Join 10 expert lectures, two panel discussions and access online learning materials including additional readings and web-based quizzes to help your understanding.
For all queries in regards to this course please contact the following :-
PLEASE ONLY CONTACT THE ONLINE STORE DIRECTLY IF YOU ARE EXPERIENCING PROBLEMS WITH YOUR DEBIT/CREDIT CARD PAYMENT, FOR ALL OTHER QUERIES RELATING TO THIS COURSE, INCLUDING CANCELLATIONS THESE SHOULD BE DIRECTED TO THE CONTACT DETAILS ABOVE.
We welcome interest from: